TY - JOUR T1 - Efficacy and safety of abrocitinib in patients with severe and/or difficult-to-treat atopic dermatitis: a post hoc analysis of the randomized phase 3 JADE COMPARE trial JO - American Journal of Clinical Dermatology UR - https://eprints.whiterose.ac.uk/id/eprint/201122 UR - http://dx.doi.org/10.1007/s40257-023-00785-5 PY - 2023/05/22 AU - Simpson EL AU - Silverberg JI AU - Thyssen JP AU - Viguier M AU - Tha莽i D AU - de Bruin-Weller M AU - Weidinger S AU - Chan G AU - DiBonaventura M AU - Biswas P AU - Feeney C et al ED - DO - DOI: 10.1007/s40257-023-00785-5 PB - Springer Science and Business Media LLC VL - 24 SP - 609 EP - 621 Y2 - 2025/07/22 ER -